Full-Time

Associate Manufacturing

Nights

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$73.4k - $85.6k/yr

Entry, Junior

Rhode Island, USA

Category
Production Planning & Scheduling
Operations & Logistics
Requirements
  • High school/GED + 2 years of manufacturing or operations work experience OR
  • Associate’s + 6 months of manufacturing or operations work experience OR
  • Bachelor’s Degree in a related field
Responsibilities
  • Under general supervision, Associate will perform operations in the manufacturing area.
  • Operations will be performed according to Standard Operating Procedures (SOP's)
  • Associate will perform and monitor critical processes, complete routine validation protocols and regularly draft and revise documents such as Manufacturing Procedures, SOP's and technical reports.
  • Associate will also perform basic troubleshooting and assist in the review of documentation for assigned functions.
  • May participate on cross-functional teams and represent the manufacturing teams.
  • Associate may also have the responsibility of owning deviations/CAPA's.
  • In addition, Associate may identify, recommend and implement improvements related to routine functions.
Desired Qualifications
  • Bachelor’s degree in Science, Engineering, or a related technical field
  • Internship or academic project experience in Manufacturing, Biotech, Medical Devices, or related industries
  • Mechanical competence with a willingness to learn equipment operation and troubleshooting
  • Familiarity with computerized systems or automation tools (experience with HMIs is a plus)
  • Basic understanding of GMP (Good Manufacturing Practices) and regulatory guidelines
  • Foundational knowledge of biotechnology processes like cell culture, purification, or aseptic techniques
  • Ability to follow written procedures and safety protocols
  • Strong interest in learning about manufacturing systems, lab equipment, and quality standards
  • Basic data analysis or statistical skills; comfortable working with Excel and other MS Office tools
  • Organized, detail-oriented, and able to manage multiple tasks with guidance
  • Clear communication skills, both written and verbal
  • Positive attitude, eager to contribute, and a team player
  • Demonstrated ability to adapt in dynamic environments and take initiative in problem-solving

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care by providing effective treatments for serious health conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.